MedPage Today on MSN
High-Fiber Diet May Boost Immunotherapy Activity in Advanced Kidney Cancer
DENVER -- Patients with advanced kidney cancer treated with immune checkpoint inhibitors (ICIs) lived longer if they consumed ...
For a limited time, patients in the US can get the first two doses of authentic, FDA-approved Wegovy(R) and Ozempic(R) for only $199 each beginning November 17, 2025 -- Also effective November 17, ...
MedPage Today on MSNOpinion
Medicine Needs a 'Millennialist' Sub-Specialty
So lately I've been wondering, does medicine need millennialists?
NPM1 mutations, one of the most common genetic drivers of AML, are now actionable for patients –– Acute unmet need in R/R ...
A 79-year-old man was admitted to a hospital in Guangzhou, China, with progressive dyspnea and edema. Echocardiography and ...
Scientists have long suspected that the virus might play a role in autoimmune diseases and researchers at Stanford University ...
Vikas Sharma, Nancy Vohra [email protected] Solanum nigrum also known as black nightshade in local dialects of Jammu and ...
Olutasidenib continued to demonstrate durable efficacy and a manageable safety profile in a broad range of patients with R/R mIDH1 AML, including those previously ...
Mama Loves to Eat on MSN
Nuts Ranked From Least to Most Healthy by Nutrition Experts
Pine Nuts - The Least Healthy Choice Pine nuts consistently rank as the least healthy of all culinary nuts. These tiny ...
Whatsapp Kashmir’s white birch, once vital to writing, architecture, culture, and medicine, has largely disappeared from the ...
Dr. Joshua Sabai spoke with Dr. Chandler Park about the latest advances in kidney cancer, highlighting clinical trials that ...
Medpage Today on MSN
Ivermectin for Kidney Cancer: Patients Have Questions, Clinicians Have Concerns
Interest in ivermectin for kidney cancer has come primarily from preclinical studies. Authors of a review from China stated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results